A Plant-Based Dietary Supplement Improves Measures of Metabolic Detoxification and the Quality of Life: A Phase II Multicenter Randomized, Blinded, Placebo-Controlled Clinical Trial
- PMID: 38144165
- PMCID: PMC10734969
A Plant-Based Dietary Supplement Improves Measures of Metabolic Detoxification and the Quality of Life: A Phase II Multicenter Randomized, Blinded, Placebo-Controlled Clinical Trial
Abstract
Background: Persistent accumulation and hindered clearance of toxins from tissues over time may promote the development and exacerbation of several diseases. Hepatic metabolic detoxification is a key physiological process responsible for the clearance of toxic substances from the body. A healthy diet with nutritional dietary supplementation may support metabolic detoxification and help mitigate the negative effects of toxin burden.
Methods: A multicenter, randomized, single-blind, controlled trial was conducted to test the effects of a dietary detoxification product (detox; n = 20) versus an active dietary control product (active control; n = 20) on selected biomarkers of metabolic detoxification, general health, and well-being following 28 days of dietary supplementation. Study participants displayed multiple symptoms commonly associated with elevated toxin burden, but otherwise healthy.
Results: The detox group displayed significantly decreased levels of red blood cell total toxic metals, decreased urine total porphyrins, and decreased urine mutagenicity potency compared with baseline. Both the detox and active control groups showed improvements in the symptoms attributed to elevated toxin burden. Fatigue and sleep disruption scores were significantly reduced in the detox group compared with baseline. No significant differences in anthropometric measures and vital signs, and no adverse events or side effects were detected in either group over the study period.
Conclusions: This study demonstrates the benefit of nutritional intervention for supporting metabolic detoxification, evidenced by significant changes in multiple detoxification biomarkers and improvement in questionnaire scores related to quality of life, general health, and well-being.
Copyright © 2023 InnoVision Professional Media Inc.
Conflict of interest statement
Author Disclosure Statement B.F.El-K., N.S., W.Z., M.W., A.D., and J.R. are either current or former employees of Standard Process Inc.; the rest of the authors declare no conflicts of interest.
Figures
References
-
- Grant DM. Detoxification pathways in the liver. J Inherit Metab Dis. 1991;14(4):421-430. doi:10.1007/BF01797915 - PubMed
-
- Yang C, Kong APS, Cai Z, Chung ACK. Persistent Organic Pollutants as Risk Factors for Obesity and Diabetes. Curr Diab Rep. 2017;17(12):132. doi:10.1007/s11892-017-0966-0 - PubMed
-
- Valkenburg S, Glorieux G, Vanholder R. Uremic Toxins and Cardiovascular System. Cardiol Clin. 2021;39(3):307-318. doi:10.1016/j.ccl.2021.04.002 - PubMed
-
- Sirasanagandla SR, Al-Huseini I, Sofin RGS, Das S. Perinatal Exposure to Bisphenol A and Developmental Programming of the Cardiovascular Changes in the Offspring. Curr Med Chem. 2022;29(24):4235-4250. doi:10.2174/092986 7328666211206111835 - PubMed
LinkOut - more resources
Full Text Sources